226 related articles for article (PubMed ID: 19690144)
1. Intracellular beta-tubulin/chaperonin containing TCP1-beta complex serves as a novel chemotherapeutic target against drug-resistant tumors.
Lin YF; Tsai WP; Liu HG; Liang PH
Cancer Res; 2009 Sep; 69(17):6879-88. PubMed ID: 19690144
[TBL] [Abstract][Full Text] [Related]
2. Defining the eukaryotic cytosolic chaperonin-binding sites in human tubulins.
Ritco-Vonsovici M; Willison KR
J Mol Biol; 2000 Nov; 304(1):81-98. PubMed ID: 11071812
[TBL] [Abstract][Full Text] [Related]
3. The cytosolic class II chaperonin CCT recognizes delineated hydrophobic sequences in its target proteins.
Rommelaere H; De Neve M; Melki R; Vandekerckhove J; Ampe C
Biochemistry; 1999 Mar; 38(11):3246-57. PubMed ID: 10079067
[TBL] [Abstract][Full Text] [Related]
4. Disrupting CCT-β : β-tubulin selectively kills CCT-β overexpressed cancer cells through MAPKs activation.
Liu YJ; Kumar V; Lin YF; Liang PH
Cell Death Dis; 2017 Sep; 8(9):e3052. PubMed ID: 28906489
[TBL] [Abstract][Full Text] [Related]
5. Newly-synthesized beta-tubulin demonstrates domain-specific interactions with the cytosolic chaperonin.
Dobrzynski JK; Sternlicht ML; Farr GW; Sternlicht H
Biochemistry; 1996 Dec; 35(49):15870-82. PubMed ID: 8961952
[TBL] [Abstract][Full Text] [Related]
6. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
7. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.
Liou JP; Hsu KS; Kuo CC; Chang CY; Chang JY
J Pharmacol Exp Ther; 2007 Oct; 323(1):398-405. PubMed ID: 17660383
[TBL] [Abstract][Full Text] [Related]
8. Folding, stability and polymerization properties of FtsZ chimeras with inserted tubulin loops involved in the interaction with the cytosolic chaperonin CCT and in microtubule formation.
Bertrand S; Barthelemy I; Oliva MA; Carrascosa JL; Andreu JM; Valpuesta JM
J Mol Biol; 2005 Feb; 346(1):319-30. PubMed ID: 15663947
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotic chaperonin CCT stabilizes actin and tubulin folding intermediates in open quasi-native conformations.
Llorca O; Martín-Benito J; Ritco-Vonsovici M; Grantham J; Hynes GM; Willison KR; Carrascosa JL; Valpuesta JM
EMBO J; 2000 Nov; 19(22):5971-9. PubMed ID: 11080144
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic chaperonin containing TCP-1: structural and functional characterization.
Melki R; Batelier G; Soulié S; Williams RC
Biochemistry; 1997 May; 36(19):5817-26. PubMed ID: 9153422
[TBL] [Abstract][Full Text] [Related]
11. Mutational screen identifies critical amino acid residues of beta-actin mediating interaction between its folding intermediates and eukaryotic cytosolic chaperonin CCT.
McCormack EA; Rohman MJ; Willison KR
J Struct Biol; 2001 Aug; 135(2):185-97. PubMed ID: 11580268
[TBL] [Abstract][Full Text] [Related]
12. Microtubule disruption induced in vivo by alkylation of beta-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents.
Legault J; Gaulin JF; Mounetou E; Bolduc S; Lacroix J; Poyet P; Gaudreault RC
Cancer Res; 2000 Feb; 60(4):985-92. PubMed ID: 10706114
[TBL] [Abstract][Full Text] [Related]
13. Luminescence studies of perturbation of tryptophan residues of tubulin in the complexes of tubulin with colchicine and colchicine analogues.
Sardar PS; Maity SS; Das L; Ghosh S
Biochemistry; 2007 Dec; 46(50):14544-56. PubMed ID: 18041823
[TBL] [Abstract][Full Text] [Related]
14. Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer.
Coghlin C; Carpenter B; Dundas SR; Lawrie LC; Telfer C; Murray GI
J Pathol; 2006 Nov; 210(3):351-7. PubMed ID: 16981251
[TBL] [Abstract][Full Text] [Related]
15. Indanocine, a microtubule-binding indanone and a selective inducer of apoptosis in multidrug-resistant cancer cells.
Leoni LM; Hamel E; Genini D; Shih H; Carrera CJ; Cottam HB; Carson DA
J Natl Cancer Inst; 2000 Feb; 92(3):217-24. PubMed ID: 10655438
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance-associated protein-overexpressing teniposide-resistant human lymphomas undergo apoptosis by a tubulin-binding agent.
Aneja R; Liu M; Yates C; Gao J; Dong X; Zhou B; Vangapandu SN; Zhou J; Joshi HC
Cancer Res; 2008 Mar; 68(5):1495-503. PubMed ID: 18316614
[TBL] [Abstract][Full Text] [Related]
17. Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity.
Gan PP; Kavallaris M
Cancer Res; 2008 Dec; 68(23):9817-24. PubMed ID: 19047161
[TBL] [Abstract][Full Text] [Related]
18. Human sarcoma cell lines MES-SA and MES-SA/Dx5 as a model for multidrug resistance modulators screening.
Wesolowska O; Paprocka M; Kozlak J; Motohashi N; Dus D; Michalak K
Anticancer Res; 2005; 25(1A):383-9. PubMed ID: 15816562
[TBL] [Abstract][Full Text] [Related]
19. Alkylation of beta-tubulin on Glu 198 by a microtubule disrupter.
Bouchon B; Chambon C; Mounetou E; Papon J; Miot-Noirault E; Gaudreault RC; Madelmont JC; Degoul F
Mol Pharmacol; 2005 Nov; 68(5):1415-22. PubMed ID: 16099845
[TBL] [Abstract][Full Text] [Related]
20. Versatile substrate protein recognition mechanism of the eukaryotic chaperonin CCT.
Jayasinghe M; Tewmey C; Stan G
Proteins; 2010 Apr; 78(5):1254-65. PubMed ID: 19950366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
